The present disclosure provides a wound dressing composition comprising cross-linked hydrogel scaffold and embedded therein anti-bacterially active honey, said activity being determined by the detection of hydrogen peroxide production rate by said wound dressing; said wound dressing further comprising at least one of a photo-initiator and/or at least one UV cross linker, the total amount of said photo-initiator and/or UV cross linker is equal or less than 0.2% w/w out of the total weight of the wound dressing. Also disclosed herein is a method of preparing the wound dressing and methods of using the same with respect to wounds, the method of preparation comprises mixing a hydrogel forming mixture comprising hydrogel forming monomer or monomers, honey and at least one photo-initiator and/or at least one UV cross-liker to form a homogenous mixture; and subjecting the homogenous mixture to UV irradiation until said homogenous mixture solidifies.

The invention relates to a functional wound dressing being able to detect and indicate the state of the wound, in particular with regard to an infection which is reported to be frequently associated with poorly healing wounds, such as chronic wounds. The present wound dressing can be used in moist wound healing and contains a substance being able to absorb wound exudate from the wound and to provide moisture to the wound.

An example female fluid collection assembly includes a fluid impermeable barrier. The fluid impermeable barrier at least defines a chamber and an opening. The female fluid collection assembly also includes at least one porous material disposed in the chamber. The porous material extends across the opening. In an embodiment, the portion of the porous material that extends across the opening include a protrusion that extends outwardly from the opening. In an embodiment, the porous material includes at least one expandable material that is configured to expand (e.g., increase in volume) when the expandable material exposed to one or more bodily fluids (e.g., urine).

Apparatus and associated methodology contemplating a securement device for securing a percutaneous feeding device having a tube operably forming a feeding passage through a stoma placed in a patient. The securement device has an adhesive-backed substrate configured to operably adhere to the patient's skin around the stoma. A connector is selectively extendable relative to the substrate and selectively moveable between an unsecured mode and a secured mode, the connector in the unsecured mode clearingly disengaging the feeding device, and the connector in the secured mode configured to impart a securement force to the feeding device to restrict its movement relative to the stoma.

The present invention relates, in part, to hydrophobically-modified polymers and foams and their use in the control of bleeding.

The present invention relates, in part, to hydrophobically-modified polymers and foams and their use in the control of bleeding.

Wound dressing compositions comprising of a bioresorbable sponge encapsulated within a polysaccharide envelope. The bioresorbable sponge is preferably comprised of collagen and oxidised regenerated cellulose. The outer polysaccharide envelope is preferably comprised of chitosan. The outer polysaccharide envelope functions to modulate the rate at which the bioresorbable sponge breaks down within a wound.

Disclosed is a dry composition comprising one or more polyols, which upon addition of an aqueous medium forms a substantially homogenous paste suitable for use in haemostasis procedures. The paste reconstitutes spontaneously upon addition of the liquid; hence no mechanical mixing is required for said paste to form. The composition may further comprise an extrusion enhancer, such as albumin. Also disclosed are methods of preparing said dry composition, a paste obtained from said dry composition and uses of said dry composition or paste for medical and surgical purposes.

The present invention relates to wound dressings, more particularly for the need-based treatment of chronic and/or infected wounds, comprising a Bronsted acid and a pH-sensitive polymer, wherein the Bronsted acid is embedded in a matrix of pH-sensitive polymer or is surrounded by pH-sensitive polymer. The present invention also relates to particles containing a Bronsted acid and a pH-sensitive polymer for use in the treatment of wounds, more particularly infected wounds and/or chronic wounds.

Diabetic wounds have elevated levels of cathepsin K, a protease enzyme, which degrades proteins, such as collagen, causing delayed wound healing. By targeting cathepsin K, diabetic wound healing is ameliorated. Methods and devices for treatment include topical application of pharmacological inhibitors of cathepsin K, for example, in the form of gel, powder, or bandage. Other methods and systems include localized genetic knock out of the cathepsin K gene by topical application of a small interfering RNA (siRNA) or antisense oligonucleotide to aid in wound healing.